A deep learning risk prediction model for overall survival in patients with gastric cancer: A multicenter study.

Computed tomography Deep learning Gastric cancer Individualized treatment Overall survival

Journal

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
ISSN: 1879-0887
Titre abrégé: Radiother Oncol
Pays: Ireland
ID NLM: 8407192

Informations de publication

Date de publication:
09 2020
Historique:
received: 05 01 2020
revised: 08 06 2020
accepted: 09 06 2020
pubmed: 17 6 2020
medline: 15 4 2021
entrez: 17 6 2020
Statut: ppublish

Résumé

Risk prediction of overall survival (OS) is crucial for gastric cancer (GC) patients to assess the treatment programs and may guide personalized medicine. A novel deep learning (DL) model was proposed to predict the risk for OS based on computed tomography (CT) images. We retrospectively collected 640 patients from three independent centers, which were divided into a training cohort (center 1 and center 2, n = 518) and an external validation cohort (center 3, n = 122). We developed a DL model based on the architecture of residual convolutional neural network. We augmented the size of training dataset by image transformations to avoid overfitting. We also developed radiomics and clinical models for comparison. The performance of the three models were comprehensively assessed. Totally 518 patients were prepared by data augmentation and fed into DL model. The trained DL model significantly classified patients into high-risk and low-risk groups in training cohort (P-value <0.001, concordance index (C-index): 0.82, hazard ratio (HR): 9.79) and external validation cohort (P-value <0.001, C-index: 0.78, HR: 11.76). Radiomics model was developed with selected 24 features and clinical model was developed with three significant clinical variables (P-value <0.05). The comparison illustrated DL model had the best performance for risk prediction of OS according to the C-index (training: DL vs Clinical vs Radiomics = 0.82 vs 0.73 vs 0.66; external validation: 0.78 vs 0.71 vs 0.72). The DL model is a powerful model for risk assessment, and potentially serves as an individualized recommender for decision-making in GC patients.

Sections du résumé

BACKGROUND AND PURPOSE
Risk prediction of overall survival (OS) is crucial for gastric cancer (GC) patients to assess the treatment programs and may guide personalized medicine. A novel deep learning (DL) model was proposed to predict the risk for OS based on computed tomography (CT) images.
MATERIALS AND METHODS
We retrospectively collected 640 patients from three independent centers, which were divided into a training cohort (center 1 and center 2, n = 518) and an external validation cohort (center 3, n = 122). We developed a DL model based on the architecture of residual convolutional neural network. We augmented the size of training dataset by image transformations to avoid overfitting. We also developed radiomics and clinical models for comparison. The performance of the three models were comprehensively assessed.
RESULTS
Totally 518 patients were prepared by data augmentation and fed into DL model. The trained DL model significantly classified patients into high-risk and low-risk groups in training cohort (P-value <0.001, concordance index (C-index): 0.82, hazard ratio (HR): 9.79) and external validation cohort (P-value <0.001, C-index: 0.78, HR: 11.76). Radiomics model was developed with selected 24 features and clinical model was developed with three significant clinical variables (P-value <0.05). The comparison illustrated DL model had the best performance for risk prediction of OS according to the C-index (training: DL vs Clinical vs Radiomics = 0.82 vs 0.73 vs 0.66; external validation: 0.78 vs 0.71 vs 0.72).
CONCLUSION
The DL model is a powerful model for risk assessment, and potentially serves as an individualized recommender for decision-making in GC patients.

Identifiants

pubmed: 32540334
pii: S0167-8140(20)30333-9
doi: 10.1016/j.radonc.2020.06.010
pii:
doi:

Types de publication

Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

73-80

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Auteurs

Liwen Zhang (L)

School of Artificial Intelligence, University of Chinese Academy of Sciences, Beijing, China; CAS Key Laboratory of Molecular Imaging, Institute of Automation, Chinese Academy of Sciences, Beijing, China.

Di Dong (D)

School of Artificial Intelligence, University of Chinese Academy of Sciences, Beijing, China; CAS Key Laboratory of Molecular Imaging, Institute of Automation, Chinese Academy of Sciences, Beijing, China.

Wenjuan Zhang (W)

Department of Radiology, Lanzhou University Second Hospital, Lanzhou, China; Key Laboratory of Medical Imaging of Gansu Province, Lanzhou, China.

Xiaohan Hao (X)

CAS Key Laboratory of Molecular Imaging, Institute of Automation, Chinese Academy of Sciences, Beijing, China.

Mengjie Fang (M)

School of Artificial Intelligence, University of Chinese Academy of Sciences, Beijing, China; CAS Key Laboratory of Molecular Imaging, Institute of Automation, Chinese Academy of Sciences, Beijing, China.

Shuo Wang (S)

CAS Key Laboratory of Molecular Imaging, Institute of Automation, Chinese Academy of Sciences, Beijing, China; Beijing Advanced Innovation Center for Big Data-Based Precision Medicine, School of Medicine, Beihang University, Beijing, China.

Wuchao Li (W)

Department of Radiology, Guizhou Provincial People's Hospital, Guiyang, China.

Zaiyi Liu (Z)

Department of Radiology, Guangdong General Hospital, Guangzhou, China. Electronic address: zyliu@163.com.

Rongpin Wang (R)

Department of Radiology, Guizhou Provincial People's Hospital, Guiyang, China. Electronic address: wangrongpin@126.com.

Junlin Zhou (J)

Department of Radiology, Lanzhou University Second Hospital, Lanzhou, China; Key Laboratory of Medical Imaging of Gansu Province, Lanzhou, China. Electronic address: ery_zhoujl@lzu.edu.cn.

Jie Tian (J)

CAS Key Laboratory of Molecular Imaging, Institute of Automation, Chinese Academy of Sciences, Beijing, China; Beijing Advanced Innovation Center for Big Data-Based Precision Medicine, School of Medicine, Beihang University, Beijing, China; Key Laboratory of Big Data-Based Precision Medicine (Beihang University), Ministry of Industry and Information Technology, Beijing, China; Engineering Research Center of Molecular and Neuro Imaging of Ministry of Education, School of Life Science and Technology, Xidian University, Xi'an, China. Electronic address: jie.tian@ia.ac.cn.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH